HII Stock Analysis: Huntington Ingalls | NYSE
Aerospace & Defense | NYSE, USA | Market Cap: 11.750m USD | 12M Return: 10.7% | US4464131063 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 163M
EPS Trend: -16.0%
Qual. Beats: 1
Rev. Trend: 85.8%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Huntington Ingalls Industries (HII) is the largest military shipbuilder in the United States, operating through three segments: Ingalls, Newport News, and Mission Technologies. The company designs, builds, overhauls, and repairs military vessels, including non-nuclear amphibious assault ships, surface combatants, and national security cutters for the U.S. Navy and Coast Guard, as well as nuclear-powered aircraft carriers and submarines. Founded in 1886 and headquartered in Newport News, Virginia, HII also provides fleet support, refueling, inactivation, and naval nuclear services.
Beyond shipbuilding, the Mission Technologies segment expands HIIs offerings into C5ISR systems, artificial intelligence and machine learning for battlefield decisions, electronic warfare, uncrewed autonomous systems, and critical nuclear operations. As a large-cap industrial within the Aerospace & Defense sub-industry, HIIs revenue is heavily tied to U.S. federal defense budgets, particularly U.S. Navy contracts, making it one of the few companies capable of designing and maintaining nuclear-powered vessels domestically.
- Columbia submarine funding accelerates Newport News backlog growth
- Mission Technologies margins expand amid defense services demand
- Ingalls destroyer cost overruns weigh on shipbuilding margins
| Net Income: 661.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -4.64 > 1.0 |
| NWC/Revenue: 4.60% < 20% (prev 1.93%; Δ 2.67% < -1%) |
| CFO/TA 0.03 > 3% & CFO 347.0m > Net Income 661.0m |
| Net Debt (3.16b) to EBITDA (1.00b): 3.14 < 3 |
| Current Ratio: 1.23 > 1.5 & < 3 |
| Outstanding Shares: last quarter (39.5m) vs 12m ago 0.25% < -2% |
| Gross Margin: 12.56% > 18% (prev 12.38%; Δ 0.18% > 0.5%) |
| Asset Turnover: 106.4% > 50% (prev 95.63%; Δ 10.79% > 0%) |
| Interest Coverage Ratio: 6.97 > 6 (EBIT TTM 683.0m / Interest Expense TTM 98.0m) |
| A: 0.05 (Total Current Assets 3.24b - Total Current Liabilities 2.63b) / Total Assets 12.7b |
| B: 0.45 (Retained Earnings 5.73b / Total Assets 12.7b) |
| C: 0.06 (EBIT TTM 683.0m / Avg Total Assets 12.4b) |
| D: 0.72 (Book Value of Equity 5.31b / Total Liabilities 7.37b) |
| Altman-Z'' = 2.91 = A |
| DSRI: 0.28 (Receivables 746.0m/2.34b, Revenue 13.2b/11.6b) |
| GMI: 0.99 (GM 12.38% / 12.56%) |
| AQI: 0.96 (AQ_t 0.42 / AQ_t-1 0.44) |
| SGI: 1.14 (Revenue 13.2b / 11.6b) |
| TATA: 0.02 (NI 661.0m - CFO 347.0m) / TA 12.7b) |
| Beneish M = -3.55 (Cap -4..+1) = AAA |
As of August 26, 2026, the stock is trading at USD 294.63 with a total of 335,210 shares traded. Over the past week, the price has changed by -7.45%, over one month by +2.45%, over three months by -7.80% and over the past year by +10.67%.
Current recommended Stop Loss: 283.50 (which is 3.8% or 1.1 ATR below the current price).
Huntington Ingalls has received a consensus analysts rating of 3.38. Therefore, it is recommended to hold HII.
- StrongBuy: 2
- Buy: 2
- Hold: 8
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 368.1 | 24.9% |
P/E Trailing = 17.7606
P/E Forward = 16.4745
P/S = 0.8912
P/B = 2.2121
P/EG = 1.0883
Revenue TTM = 13.2b USD
EBIT TTM = 683.0m USD
EBITDA TTM = 1.00b USD
Long Term Debt = 2.70b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 3.17b USD (from shortLongTermDebtTotal, last quarter) + Leases 233.0m
Net Debt = 3.16b USD (calculated: Debt 3.17b - CCE 12.0m)
Enterprise Value = 14.9b USD (11.8b + Debt 3.17b - CCE 12.0m)
Interest Coverage Ratio = 6.97 (Ebit TTM 683.0m / Interest Expense TTM 98.0m)
EV/FCF = 39.64x (Enterprise Value 14.9b / FCF TTM 376.0m)
FCF Yield = 2.52% (FCF TTM 376.0m / Enterprise Value 14.9b)
FCF Margin = 2.85% (FCF TTM 376.0m / Revenue TTM 13.2b)
Net Margin = 5.01% (Net Income TTM 661.0m / Revenue TTM 13.2b)
Gross Margin = 12.56% ((Revenue TTM 13.2b - Cost of Revenue TTM 11.5b) / Revenue TTM)
Gross Margin QoQ = 13.22% (prev 13.17%)
Tobins Q-Ratio = 1.18 (Enterprise Value 14.9b / Total Assets 12.7b)
Interest Expense / Debt = 3.09% (Interest Expense 98.0m / Debt 3.17b)
Taxrate = 21.68% (183.0m / 844.0m)
NOPAT = 534.9m (EBIT 683.0m * (1 - 21.68%))
Current Ratio = 1.23 (Total Current Assets 3.24b / Total Current Liabilities 2.63b)
Debt / Equity = 0.60 (Debt 3.17b / totalStockholderEquity, last quarter 5.31b)
Debt / EBITDA = 3.14 (Net Debt 3.16b / EBITDA 1.00b)
Debt / FCF = 8.39 (Net Debt 3.16b / FCF TTM 376.0m)
Total Stockholder Equity = 5.13b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.33% (Net Income 661.0m / Total Assets 12.7b)
RoE = 12.89% (Net Income TTM 661.0m / Total Stockholder Equity 5.13b)
RoCE = 8.72% (EBIT 683.0m / Capital Employed (Equity 5.13b + L.T.Debt 2.70b))
RoIC = 5.33% (NOPAT 534.9m / Invested Capital 10.0b)
WACC = 6.08% (E(11.8b)/V(14.9b) * Re(7.06%) + D(3.17b)/V(14.9b) * Rd(3.09%) * (1-Tc(0.22)))
Discount Rate = 7.06% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -12.83 | Cagr: 0.0%
[DCF] Terminal Value 73.10% ; FCFF base≈593.6m ; Y1≈520.6m ; Y5≈420.6m
[DCF] Fair Price = 91.23 (EV 6.75b - Net Debt 3.16b = Equity 3.59b / Shares 39.4m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -16.02 | EPS CAGR: -2.15% | SUE: 2.21 | # QB: 1
Revenue Correlation: 85.77 | Revenue CAGR: 5.05% | SUE: 1.58 | # QB: 1
EPS current Quarter (2026-09-30): EPS=4.51 | Chg30d=-3.03% | Revisions=-30% | Analysts=11
EPS current Year (2026-12-31): EPS=18.54 | Chg30d=+6.86% | Revisions=+70% | GrowthEPS=+20.4% | GrowthRev=+6.8%
EPS next Year (2027-12-31): EPS=20.84 | Chg30d=+3.28% | Revisions=+58% | GrowthEPS=+12.4% | GrowthRev=+6.3%
[Analyst] Revisions Ratio: +42% (up=17, down=6)